EPISODE · Jan 31, 2022 · 7 MIN
Spinraza Plus Zolgensma Offers Little Extra Benefit in Type 1, Study Suggests
from The Spinal Muscular Atrophy Podcast with Kevin Schaefer · host SMA News Today
SMA News Today’s multimedia associate, Price Wooldridge, reads an article about how a small group of children given the gene therapy after Spinraza's start showed only slight further gains; early treatment most important.Also, in her latest vlog DeAnn Runge explores the topic of furry friends. Pets are an important aspect of her life. She explains how she feels pets can benefit the lives of anyone living with SMA. Watch here: https://youtu.be/9Etax9E4cH0 Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/.
Embed this episode
Ready to play
Spinraza Plus Zolgensma Offers Little Extra Benefit in Type 1, Study Suggests
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.